Showing results (31-40 of 17,407) with videos related to
Sort By:
Pageof 1,741
Bioorganic & Medicinal Chemistry|September 11, 2009
Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depressionJohn R Cashman, Senait GhirmaiInvestigational New Drugs|September 11, 2020
Pancreatic cancer drug-sensitivity predicted by synergy of p53-Activator Wnt Inhibitor-2 (PAWI-2) and protein biomarker expressionJiongjia Cheng, John R CashmanChemical Research in Toxicology|September 1, 2009
Nerve agent analogues that produce authentic soman, sarin, tabun, and cyclohexyl methylphosphonate-modified human butyrylcholinesteraseCynthia Gilley, Mary MacDonald, Florian Nachon, et al.Current Topics in Medicinal Chemistry|July 19, 2005
Dynamic medicinal chemistry in the elaboration of morphine-6-glucuronide analogsJohn R Cashman, James M MacDougallInvestigational New Drugs|May 24, 2024
Effect of PAWI-2 on pancreatic cancer stem cell tumorsJohn R Cashman, Emily A CashmanThe Journal of Pharmacology and Experimental Therapeutics|May 13, 2014
Potent inhibition of alcohol self-administration in alcohol-preferring rats by a κ-opioid receptor antagonistJohn R Cashman, Marc R AzarBiochemistry|June 6, 2014
Novel human butyrylcholinesterase variants: toward organophosphonate detoxicationMary Dwyer, Sacha Javor, Daniel A Ryan, et al.BMC Medical Genetics|January 30, 2007
Transient trimethylaminuria related to menstruationMakiko Shimizu, John R Cashman, Hiroshi YamazakiDrug Metabolism and Disposition: the Biological Fate of Chemicals|January 28, 2004
Effect of total parenteral nutrition and choline on hepatic flavin-containing and cytochrome P-450 monooxygenase activity in ratsJohn R Cashman, Virginie Lattard, Jing LinDrug Metabolism and Disposition: the Biological Fate of Chemicals|December 18, 2008
Hepatic flavin-containing monooxygenase gene regulation in different mouse inflammation modelsJun Zhang, Madhusudana R Chaluvadi, Rob Reddy, et al.Pageof 1,741